What clinical trials are available for pancreatic cancer

April 9, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Clinical Trials for Pancreatic Cancer

Clinical trials are an important part of pancreatic cancer treatment, and I want to help you understand what's available and how to find them.

Why Clinical Trials Matter for Pancreatic Cancer

According to Let's Win Pancreatic Cancer, clinical trials are particularly important because current standard treatments often aren't effective long-term. Since pancreatic cancer is so challenging to treat, participating in a clinical trial may offer access to cutting-edge treatments that could work better for your specific situation.

Here's an important concept: clinical trials don't mean you're giving up standard care. As one oncologist explains, think of it as "standard of care plus" — you'll still receive the best current treatments, but may also get access to newer approaches being tested.

Types of Trials Currently Available

Based on recent research updates, here are the main categories of pancreatic cancer trials:

1. Targeted Therapy Trials (Mutation-Based)

  • KRAS-targeted drugs: According to Dr. [removed] Strickler's presentation on pancreatic cancer advances, KRAS mutations drive about 87% of pancreatic cancers. New drugs like RMC-6236 are being tested in phase III trials to target these mutations specifically
  • BRCA mutation trials: For patients with BRCA1, BRCA2, or PALB2 mutations, PARP inhibitors (like olaparib) are FDA-approved options
  • Basket trials: These enroll patients with different cancer types but the same genetic mutation (like NTRK, ROS1, or ALK mutations)

2. Immunotherapy Trials

  • Trials combining chemotherapy with immunotherapy agents
  • Vaccine-based approaches (like GVAX) being tested in combination with other drugs
  • Phase IIb/III trials testing immunotherapy added to standard chemotherapy

3. Chemotherapy Combination Trials

  • NALIRIFOX: FDA-approved combination of irinotecan liposome (ONIVYDE) with oxaliplatin, fluorouracil, and leucovorin for first-line metastatic disease
  • Sequential chemotherapy approaches combining FOLFIRINOX with gemcitabine/nab-paclitaxel

4. Radiation + Chemotherapy Trials

  • Trials using proton beam radiation combined with capecitabine (Xeloda) to make borderline resectable tumors surgically removable
  • SBRT (stereotactic body radiation therapy) studies for locally advanced disease

5. Supportive Care Trials

  • Cachexia treatment: Ponsegromab (Pfizer) is being tested to address cancer-related weight loss and muscle loss, which affects quality of life

6. Biomarker-Based Trials

  • The PASS-01 study uses organoid technology and molecular profiling to match patients with treatments based on their tumor's genetic fingerprint
  • Trials focusing on pancreatic cancer subtypes (basal-like vs. classical)

How to Find Clinical Trials

Let's Win Pancreatic Cancer recommends several resources:

  1. Let's Win Trial Finder — A specialized tool that lets you search by disease stage, location, and other factors
  2. ClinicalTrials.gov — The National Institutes of Health database with detailed information
  3. Talk to your oncologist — Ask specifically: "Are there any clinical trials available for my stage and type of pancreatic cancer?"
  4. Get a second opinion — Other oncologists may be aware of trials your current doctor hasn't mentioned

Important Things to Know About Trials

You keep standard care: Even in the control group, you receive current best treatment
Safety monitoring: Trials are reviewed by strict regulatory boards that monitor for safety
Costs are covered: Treatment costs and special tests are covered; some trials cover travel
Better monitoring: Trial participants often receive more frequent check-ups and closer attention
Early access: You may get access to promising new treatments years before FDA approval

Questions to Ask Your Doctor

  1. "Are there any clinical trials that match my cancer stage and genetic profile?"
  2. "Have you done molecular profiling on my tumor? Can I see the report?" (This is important — keep a copy with you)
  3. "What are the pros and cons of a trial versus standard treatment for my situation?"
  4. "How often would I need to visit the clinic, and what extra tests would be involved?"
  5. "Are there trials available now, or should I wait until after my first treatment?"

A Note on Timing

According to Let's Win Pancreatic Cancer, many patients think of trials as a "last resort," but for pancreatic cancer specifically, trials should be considered from the very beginning of treatment. Because this disease is so aggressive, getting access to cutting-edge treatments early may offer your best chance at better outcomes.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...

TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2